2010 related articles for article (PubMed ID: 24792712)
1. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.
Kanagaraj N; Beiping H; Dheen ST; Tay SS
Neuroscience; 2014 Jul; 272():167-79. PubMed ID: 24792712
[TBL] [Abstract][Full Text] [Related]
2. Cdk5/p25 specific inhibitory peptide TFP5 rescues the loss of dopaminergic neurons in a sub-acute MPTP induced PD mouse model.
Zhang Q; Xie H; Ji Z; He R; Xu M; He Y; Huang J; Pan S; Hu Y
Neurosci Lett; 2016 Oct; 632():1-7. PubMed ID: 27542341
[TBL] [Abstract][Full Text] [Related]
3. Melatonin attenuates MPTP-induced neurotoxicity via preventing CDK5-mediated autophagy and SNCA/α-synuclein aggregation.
Su LY; Li H; Lv L; Feng YM; Li GD; Luo R; Zhou HJ; Lei XG; Ma L; Li JL; Xu L; Hu XT; Yao YG
Autophagy; 2015; 11(10):1745-59. PubMed ID: 26292069
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-124 regulates the expression of p62/p38 and promotes autophagy in the inflammatory pathogenesis of Parkinson's disease.
Yao L; Zhu Z; Wu J; Zhang Y; Zhang H; Sun X; Qian C; Wang B; Xie L; Zhang S; Lu G
FASEB J; 2019 Jul; 33(7):8648-8665. PubMed ID: 30995872
[TBL] [Abstract][Full Text] [Related]
5. Loss of collapsin response mediator protein 4 suppresses dopaminergic neuron death in an 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease.
Tonouchi A; Nagai J; Togashi K; Goshima Y; Ohshima T
J Neurochem; 2016 Jun; 137(5):795-805. PubMed ID: 26991935
[TBL] [Abstract][Full Text] [Related]
6. Neuroprotective microRNA-381 Binds to Repressed Early Growth Response 1 (EGR1) and Alleviates Oxidative Stress Injury in Parkinson's Disease.
Guo S; Gao Y; Zhao Y
ACS Chem Neurosci; 2023 Jun; 14(11):1981-1991. PubMed ID: 37166273
[TBL] [Abstract][Full Text] [Related]
7. Sphingosine kinase 2 and sphingosine-1-phosphate promotes mitochondrial function in dopaminergic neurons of mouse model of Parkinson's disease and in MPP+ -treated MN9D cells in vitro.
Sivasubramanian M; Kanagaraj N; Dheen ST; Tay SS
Neuroscience; 2015 Apr; 290():636-48. PubMed ID: 25637806
[TBL] [Abstract][Full Text] [Related]
8. Peptide TFP5/TP5 derived from Cdk5 activator P35 provides neuroprotection in the MPTP model of Parkinson's disease.
Binukumar BK; Shukla V; Amin ND; Grant P; Bhaskar M; Skuntz S; Steiner J; Pant HC
Mol Biol Cell; 2015 Dec; 26(24):4478-91. PubMed ID: 26399293
[TBL] [Abstract][Full Text] [Related]
9. Calpain-regulated p35/cdk5 plays a central role in dopaminergic neuron death through modulation of the transcription factor myocyte enhancer factor 2.
Smith PD; Mount MP; Shree R; Callaghan S; Slack RS; Anisman H; Vincent I; Wang X; Mao Z; Park DS
J Neurosci; 2006 Jan; 26(2):440-7. PubMed ID: 16407541
[TBL] [Abstract][Full Text] [Related]
10. HOTAIR drives autophagy in midbrain dopaminergic neurons in the substantia nigra compacta in a mouse model of Parkinson's disease by elevating NPTX2
Lang Y; Li Y; Yu H; Lin L; Chen X; Wang S; Zhang H
Aging (Albany NY); 2020 May; 12(9):7660-7678. PubMed ID: 32396526
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of miR-34a, miR-141, and miR-9 in MPP+-treated differentiated PC12 cells as a model of Parkinson's disease.
Rostamian Delavar M; Baghi M; Safaeinejad Z; Kiani-Esfahani A; Ghaedi K; Nasr-Esfahani MH
Gene; 2018 Jul; 662():54-65. PubMed ID: 29631008
[TBL] [Abstract][Full Text] [Related]
12. [Effect of phosphorylated c-Jun expression on COX-2 expression in the substantia nigra of MPTP mouse model of subacute Parkinson disease].
Wang YS; Zhou JP; Wei ZF; Tian QY; Zhou HX; Zhang YX
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Aug; 27(8):1199-202, 1205. PubMed ID: 17715026
[TBL] [Abstract][Full Text] [Related]
13. Geniposide reduces α-synuclein by blocking microRNA-21/lysosome-associated membrane protein 2A interaction in Parkinson disease models.
Su C; Yang X; Lou J
Brain Res; 2016 Aug; 1644():98-106. PubMed ID: 27173998
[TBL] [Abstract][Full Text] [Related]
14. Anti-apoptotic effect of modified Chunsimyeolda-tang, a traditional Korean herbal formula, on MPTP-induced neuronal cell death in a Parkinson's disease mouse model.
Li H; Park G; Bae N; Kim J; Oh MS; Yang HO
J Ethnopharmacol; 2015 Dec; 176():336-44. PubMed ID: 26593210
[TBL] [Abstract][Full Text] [Related]
15. Systemically administered neuregulin-1β1 rescues nigral dopaminergic neurons via the ErbB4 receptor tyrosine kinase in MPTP mouse models of Parkinson's disease.
Depboylu C; Rösler TW; de Andrade A; Oertel WH; Höglinger GU
J Neurochem; 2015 May; 133(4):590-7. PubMed ID: 25581060
[TBL] [Abstract][Full Text] [Related]
16. miR-425 deficiency promotes necroptosis and dopaminergic neurodegeneration in Parkinson's disease.
Hu YB; Zhang YF; Wang H; Ren RJ; Cui HL; Huang WY; Cheng Q; Chen HZ; Wang G
Cell Death Dis; 2019 Aug; 10(8):589. PubMed ID: 31383850
[TBL] [Abstract][Full Text] [Related]
17. The peptidyl-prolyl isomerase Pin1 up-regulation and proapoptotic function in dopaminergic neurons: relevance to the pathogenesis of Parkinson disease.
Ghosh A; Saminathan H; Kanthasamy A; Anantharam V; Jin H; Sondarva G; Harischandra DS; Qian Z; Rana A; Kanthasamy AG
J Biol Chem; 2013 Jul; 288(30):21955-71. PubMed ID: 23754278
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effect of silymarin in a MPTP mouse model of Parkinson's disease.
Pérez-H J; Carrillo-S C; García E; Ruiz-Mar G; Pérez-Tamayo R; Chavarría A
Toxicology; 2014 May; 319():38-43. PubMed ID: 24607817
[TBL] [Abstract][Full Text] [Related]
19. Neuroprotective Effects of the DPP4 Inhibitor Vildagliptin in In Vivo and In Vitro Models of Parkinson's Disease.
Pariyar R; Bastola T; Lee DH; Seo J
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216503
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effects of piperine on the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease mouse model.
Yang W; Chen YH; Liu H; Qu HD
Int J Mol Med; 2015 Nov; 36(5):1369-76. PubMed ID: 26648012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
